| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Learn more about Neuroone Medical Technologies Corp’s (NMTC) stock grades for Momentum, Estimate Revisions and Quality and determine whether this Advanced Medical Equipment & Technology stock meets your investment needs.
Issac Deleon
| Share Statistics | NMTC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $14.5 | $334.8 | 8% |
|
| Shares Out (Mil) | 8.5 | 41.7 | 19% |
|
| Institutional Ownership | 52.0% | 77.3% | 36% |
|
| Float (Mil) | 5.8 | 34.7 | 13% |
|
| Beta | 0.51 | 0.86 | 29% |
|
| Avg Daily Volume (000s) | 37 | 266 | 26% |
|
| Price Change (52-week) |
(66.5%) | 60.7% | 10% |
|
| Growth | NMTC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 44.8% | 11.8% | 95% |
|
| Net Income (5yr) | 23.3% | (5.8%) | 77% |
|
| EPS (5yr) | 48.7% | 10.7% | 92 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (28.9%) | (16.1%) | 20% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NMTC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $13 | $152 | 10% |
|
| Net Income (TTM) (Mil) | ($7) | ($11) | 32% |
|
| EPS (TTM) | ($0.798) | ($0.500) | 23% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($2) | 22% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $1 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 10% |
|
| Enterprise Value (Q1) (Mil) | $26 | $304 | 12% |
|
| Valuation | NMTC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.71 | 2.88 | 61% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | NMTC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 24.7% | 59.1% | 27% |
|
| Net Margin | (52.2%) | (7.7%) | 11% |
|
| ROA | (107.8%) | (13.7%) | 5% |
|
| ROE | (204.4%) | (15.9%) | 4% |
|
| Liabilities to Assets | 31.7% | 44.9% | 23% |
|
| F-Score | 5 | 4 | 51% |
|
NeuroOne Medical Technologies Corporation did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
